CClinicalTrials.gg
CompletedNCT05317208prevalenceUpdated Apr 7, 2022

Prevalence of Periodontitis in Sample of Egyptian Population

An observational study in Periodontitis, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-04-07.

Sponsored by Cairo University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
581
Ages
18 Years and older
Sex
All
01

Study summary

Prevalence of Periodontitis on a Sample of Adult Egyptian Population: A Cross-sectional study

Read the detailed description

The aim of this study is to assess the prevalence, severity, and extent of periodontitis through full-mouth examination of CAL, and its association withsociodemographic, behavioral and environmental risk factors, in anEgyptian sample will be recruited from diagnostic center at Faculty of Dentistry, Cairo University, Egypt.

02

Conditions studied

  • Periodontitis

Browse trials for

03

In context

Periodontitis

1,635 studies on the registry are indexed under Periodontitis; 327 are open to participants now.

This study's enrollment of 581 is above the median of 90 across 428 observational studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

All Adult patients attending at the diagnostic center at the Faculty of Dentistry above 18 years old.

Inclusion criteria

    • All Adult patients attending at the diagnostic center at the Faculty of Dentistry above 18 years old.

Exclusion criteria

Exclusion criteria:

  1. patients undergone periodontal therapy in the last 6 months.
  2. patients with psychomotor dysfunction.
  3. Patients less than 18 years old.
  4. Edentulous patients
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
581 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Quetionaire on Percentage of periodontitis on egypt

    Description of prevalence of periodontitis on sample of Egyptians by filling a questionaire

    Time frame: Two months

Secondary outcomes

  1. Socioeconomic level and periodontitis (questionaire)

    Relation between Socioeconomic level and its impact on prevalence of periodontitis.

    Time frame: Two months

07

Study locations

1 site
  • Faculty of Dentistry
    Cairo, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05317208
Lead sponsor
Cairo University
Responsible party
Mohamed Ashraf Mohamed Abdelbary (Director, Cairo University) — Principal investigator
First posted
Apr 7, 2022
Start date
May 5, 2019
Primary completion
May 5, 2021
Completion
Mar 1, 2022
Last update
Apr 7, 2022

Study contacts

Reham O Ibrahim, PHD
study director · lecturer

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion